ScholarIQanswers from OpenAlex

A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children

PaperCitations, authors & open-access status

A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children is a paper indexed in ScholarIQ from OpenAlex.

How many citations does A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children have?

ScholarIQcitation count

A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children has 21 citations in the OpenAlex counts ScholarIQ stores.

When was A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children published?

ScholarIQyear

A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children has 2020 year in the ScholarIQ index.

What is the open-access status of A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children?

ScholarIQoa status

A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children has gold oa status in the ScholarIQ index.

What is the DOI of A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children?

ScholarIQdoi

The DOI for A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children is on the source record.

What is the PMID of A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children?

ScholarIQpmid

The PMID for A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children is on the source record.

What is the OpenAlex record for A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children?

ScholarIQopenalex

The OpenAlex for A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial